BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6232205)

  • 1. Role of autorosette forming cells in antibody synthesis in vitro: suppressive activity of ARFC in humoral immune response.
    Khansari N; Petrini M; Ambrogi F; Goldschmidt-Clermont P; Fudenberg HH
    Immunobiology; 1984 Jan; 166(1):1-11. PubMed ID: 6232205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of mitogen-induced autorosette-forming cells: correlation with T-cell subsets and with lymphocyte proliferative responses to mitogens.
    Ichikawa Y; Lavastida MT; Gonzalez EB; Daniels JC
    Cell Immunol; 1983 Mar; 76(2):351-60. PubMed ID: 6601521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of mitogen-induced autorosette-forming cells to interleukin 2 (T-cell growth factor).
    Ichikawa Y; Daniels JC
    Cell Immunol; 1983 Feb; 76(1):105-12. PubMed ID: 6600976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PNP enzyme in autologous rosette-forming cells.
    Goldschmidt-Clermont P; Petrini M; Khansari N; Fudenberg HH
    Cell Immunol; 1984 Sep; 87(2):340-7. PubMed ID: 6235921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme analysis of autologous rosette-forming cells.
    Plum J; de Smedt M; Sabbe L
    Scand J Immunol; 1984 Mar; 19(3):199-204. PubMed ID: 6424230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autorosette forming cells: phenotypic analysis, specificity and role in the autologous mixed lymphocyte reaction.
    Fournier C; Nalet V; Charreire J
    Behring Inst Mitt; 1983 May; (72):89-94. PubMed ID: 6242346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of concanavalin A-induced suppressor and helper cells by autologous erythrocyte rosette formation and monoclonal antibody methods].
    Takada S; Sakane T; Ueda Y; Murakawa Y; Kotani H; Tsunematsu T
    Arerugi; 1983 Apr; 32(4):213-20. PubMed ID: 6227308
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of sex hormones on human T cell activation by concanavalin A.
    Yron I; Langer A; Weinstein T; Sahar E; Lidor Y; Pardo Y; Katz I; Shohat L; Kalechman Y; Ovadia J
    Nat Immun Cell Growth Regul; 1991; 10(1):32-44. PubMed ID: 2057020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active T rosettes, human autologous T rosettes, OKT8 and OKT4 cells, con A-induced suppressive activity, and autoantibodies: clinical correlations.
    Schandené L; Vanden Steen F; Romasco F; Wybran J
    Clin Immunol Immunopathol; 1983 Aug; 28(2):147-54. PubMed ID: 6223764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
    Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active rosette forming cells as a possible functional subpopulation of human peripheral T lymphocytes.
    Harada M; Ishino C; Mori T; Hattori K
    Jpn J Exp Med; 1977 Dec; 47(6):489-94. PubMed ID: 305494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human T lymphocyte E rosette formation by neutrophils and hydrogen peroxide. Differential sensitivity between helper and suppressor T lymphocytes.
    Staite ND; Messner RP; Zoschke DC
    J Immunol; 1987 Oct; 139(7):2424-30. PubMed ID: 2958549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous rosette-forming T cells and their relationship to OKT4+ and OKT8+ cells in chronic HBV infection.
    Victorino RM; Lucas M; de Moura MC
    J Clin Lab Immunol; 1986 Jul; 20(3):137-41. PubMed ID: 2943900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and activity of autorosette forming cells in Con-A activated PBL from women with hyperplasia or carcinoma of the endometrium--possible role of estrogens.
    Yron I; Kalechman Y; Langer A; Lidor I; Luria B; Luria H; Ovadia J; Pardo Y; Shohat L
    J Clin Lab Immunol; 1990 Nov; 33(3):135-43. PubMed ID: 1967003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of autorosette-forming cells in T-cell lymphoma.
    Tamura K; Aratake Y; Endo Y; Ohtaki S
    Leuk Res; 1984; 8(2):275-83. PubMed ID: 6609283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concanavalin A induced suppressor cell activity and autorosette forming cells in chronic myeloid leukemia patients.
    Somasundaram R; Advani SH; Gangal SG
    Br J Cancer; 1983 Dec; 48(6):783-90. PubMed ID: 6228243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self recognition by autologous mixed lymphocyte reaction-primed cells.
    Tomonari K; Wakisaka A; Aizawa M
    J Immunol; 1980 Oct; 125(4):1596-600. PubMed ID: 6447728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of phytohaemagglutinin-induced autorosette formation of human peripheral blood lymphocytes by RNA or protein synthesis inhibitor.
    Hyodo S; Kishi T; Kittaka E; Suzawa T; Tanabe A; Tanaka Y; Sakano T; Usui T
    Clin Exp Immunol; 1983 Jul; 53(1):140-4. PubMed ID: 6191894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of human autorosette forming cells by phorbol myristate acetate.
    Sakano T; Hyodo S; Kittaka E; Tanaka Y; Usui T
    Clin Exp Immunol; 1982 Sep; 49(3):665-9. PubMed ID: 7172500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in autorosette-forming lymphocytes in thyroid diseases.
    Endo Y; Aratake Y; Kotani T; Kuribayashi T; Tamura K; Ohtaki S
    Endocrinol Jpn; 1984 Oct; 31(5):627-34. PubMed ID: 6335085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.